Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Sankyo discloses sulfonamide derivatives for diabetes

July 5, 1996

Lilly discloses antiobesity proteins

July 5, 1996

NPY1 ligands claimed by Pfizer

July 5, 1996

Low-dose lovastatin + niacin shows good efficacy and safety in patient study

July 5, 1996

Ono terminates CholestaGel agreement with GelTex

July 5, 1996

Fortical phase I dosing data revised

July 5, 1996

HHS scientist discovers cartilage formation stimulant

July 5, 1996

Vasodilator cream shows positive results in trials

June 28, 1996

Zonagen's Vasomax covered under U.S. patent

June 28, 1996

Merck & Co. reveals growth hormone release promoters

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...